ION251

· Ionis Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ION251, covering 2024-10-31 to 2024-10-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ION251 Administered to Patients With Relapsed/Refractory Multiple Myeloma [Phase 1]